The Turkish Fear of Pain Questionnaire
Launched by AKDENIZ UNIVERSITY · Jun 8, 2022
Trial Information
Current as of July 24, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is studying a special questionnaire called the Fear of Pain Questionnaire for Children (FOPQ-C), which helps researchers understand how fear of pain affects children with chronic headaches. Chronic pain is a serious issue for many children, with about 25% experiencing it, and this study aims to see how well this questionnaire works in the Turkish community. By understanding children's fears related to pain, healthcare providers hope to improve treatment and support for these young patients.
To participate in the study, children must be diagnosed with chronic pain and be able to understand and answer questions. They should also speak Turkish as their first language. Healthy children aged 5-18 can also join but must not have any psychiatric or neurological issues. Participants will be asked not to take pain relief medications for 48 hours before answering the questions. This study is currently recruiting participants and aims to help improve care for children dealing with chronic pain in Turkey.
Gender
ALL
Eligibility criteria
- Inclusion criteria of children with chronic pain:
- • (1) Being diagnosed with chronic pain. (2) To have the cognitive ability to answer questions for assessment. (3) Completing the test-retest assessment. (4) To be the native language Turkish.
- * Exclusion criteria for children with chronic pain:
- • 1. Uncontrollable psychological diseases (eg, attention deficit hyperactivity disorder, autism spectrum disorder, schizophrenia, bipolar disorder, major depressive disorder), specific pathologies, will not be included in the study.
- • 2. Patients who started a new treatment during the study or 6 weeks before the study.
- • 3. Study participants will be instructed not to take analgesics for 48 hours prior to assessments.
- Inclusion criteria for healthy children:
- • 1. between the ages of 5-18.
- • 2. Not having any psychiatric or neurological diagnosis.
- • 3. To be the native language Turkish.
- Exclusion criteria for healthy children:
- • 1. Families and children who did not agree to participate in the study.
- • 2. To have received medical treatment for any neuropsychiatric disorder.
About Akdeniz University
Akdeniz University is a leading academic institution located in Antalya, Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Akdeniz University leverages its extensive expertise and state-of-the-art facilities to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a diverse range of stakeholders, including healthcare professionals, researchers, and industry partners, to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Through its dedication to excellence in research, Akdeniz University plays a pivotal role in contributing to the development of new therapies and enhancing the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Antalya, , Turkey
Patients applied
Trial Officials
Ozgun Kaya Kara, Assoc. Prof
Study Director
Akdeniz University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials